Seraph Biosciences
Business Services · Michigan, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1001 Woodward Ave Ste 500, Detroit, Mich...Phone Number
(313) 759-8009Website
www.seraspec.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Seraph Biosciences
Seraph Biosciences specializes in real-time pathogen detection at the point of care through its innovative Seraspec® technology, which utilizes Raman Spectroscopy to identify bacterial, viral, and fungal pathogens without the need for traditional laboratory methods. Their portable solution enhances safety, efficiency, and accuracy, enabling healthcare providers to make informed decisions quickly. The company aims to address the global crisis of antimicrobial resistance and pandemic viruses by providing cost-effective technologies for healthcare optimization. Target clients include healthcare providers seeking to improve clinical outcomes and streamline infection management.Explore more
Seraph Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Seraph Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Seraph Biosciences is spiking on competitors!
Seraph Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Seraph Biosciences has new funding data
Click to see if Seraph Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Seraph Biosciences has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Seraph Biosciences launches new products
Congratulate Masked Content for being promoted to Masked Content at Seraph Biosciences
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Seraph Biosciences recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Seraph Biosciences as Masked Content
Find 3 more new buyers
Compare Similar Companies to Seraph Biosciences
Compare insights from companies similar to Seraph Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Seraph Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Seraph Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Seraph Biosciences.
Seraph Biosciences financials insights
Gather financial insights about Seraph Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Private Equity
$1.5M
2021
Debt
$168K
Seraph Biosciences Tech Stack
A closer look at the technologies used by Seraph Biosciences
Most Recent Scoops
Open Position
Left Company
Executive Move
Fouad Sayegh, Vice President, Product Development, has left the organization and now serves as the Director, Program Management at Qiagen.
Funding
Seraph Biosciences has received an SBA PPP loan in the amount of $168,410 from Bank of America resulting in the retention of 9 jobs.
Funding
Seraph Biosciences News & Media
Zomedica Files U.S. Patent Application for Fecal Parasite Detection
Assays expected to be capable of broad-based fecal pathogen identification in minutes for diagnosing infections in dogs and cats - complementary to Zomedica’s development work related to urine pathogens Assays expected to be capable of broad-based fecal pathogen identification in minutes for diagnosing infections in dogs and cats - complementary to Zomedica’s development work related to urine pathogensZomedica Signs Agreement With Seraph Biosciences for Innovative Veterinary Point-of-Care Diagnostic
Exclusive agreement intended to bring human medical diagnostic technology to the veterinary practice workflow Exclusive agreement intended to bring human medical diagnostic technology to the veterinary practice workflow
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Seraph Biosciences
Sign Up For FreeTo access detailed company insights
Seraph Biosciences specializes in real-time pathogen detection at the point of care through its innovative Seraspec® technology, which utilizes Raman Spectroscopy to identify bacterial, viral, and fungal pathogens without the need for traditional laboratory methods. Their portable solution enhances safety, efficiency, and accuracy, enabling healthc... Read More
